amobarbital has been researched along with Libman-Sacks Disease in 1 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A brief differential diagnosis of catatonia is also included." | 1.26 | Catatonia and systemic lupus erythematosus. ( Kronfol, Z; Schlesser, M; Tsuang, MT, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kronfol, Z | 1 |
| Schlesser, M | 1 |
| Tsuang, MT | 1 |
1 other study available for amobarbital and Libman-Sacks Disease
| Article | Year |
|---|---|
Catatonia and systemic lupus erythematosus.
Topics: Adult; Amobarbital; Catatonia; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemi | 1977 |